NCT03488550View on ClinicalTrials.gov

Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 23, 2018

Primary Completion Date

August 3, 2018

Study Completion Date

August 3, 2018

Conditions
Open-angle Glaucoma
Interventions
BIOLOGICAL

ANX007

Single ascending dose

Trial Locations (1)

92663

Eye Research Foundation, Newport Beach

All Listed Sponsors
lead

Annexon, Inc.

INDUSTRY

NCT03488550 - Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma | Biotech Hunter | Biotech Hunter